Showing results (31-40 of 233) with videos related to

Sort By:
Pageof 24
JAMA Dermatology|February 22, 2013
Eruptive cherry hemangiomatosis associated with multicentric Castleman disease: a case report and diagnostic clueDavid C Fajgenbaum, David Fajgenbaum, Misha Rosenbach, et al.
Blood|October 9, 2014
Curing myeloma at last: defining criteria and providing the evidenceBart Barlogie, Alan Mitchell, Frits van Rhee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Race-Dependent Differences in Risk, Genomics, and Epstein-Barr Virus Exposure in Monoclonal Gammopathies: Results of SWOG S0120Madhav V Dhodapkar, Rachael Sexton, Antje Hoering, et al.
European Journal of Haematology|July 9, 2021
Combinatorial treatment for unresectable unicentric Castleman diseaseMeera Mohan, James C Meek, Mary Elizabeth Meek, et al.
Ejhaem|September 2, 2022
Global public awareness of Castleman disease and TAFRO syndrome between 2015 and 2021: A Google Trends analysisYoshito Nishimura, Midori Filiz Nishimura, David C Fajgenbaum, et al.
Cureus|December 1, 2025
Disseminated Bartonella henselae Infection in a Patient With Relapsed/Refractory Multiple Myeloma Following Autologous Stem Cell TransplantationSanjay Muttineni, Sasya Dronavalli, Sharmilan Thanendrarajan, et al.
Blood Advances|July 6, 2022
Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman diseaseFrits van Rhee, Adam Rosenthal, Karan Kanhai, et al.
Haematologica|August 30, 2008
Mobilization of peripheral blood stem cells in myeloma with either pegfilgrastim or filgrastim following chemotherapyGuido Tricot, Bart Barlogie, Maurizio Zangari, et al.
British Journal of Haematology|March 29, 2008
Eight-year median survival in multiple myeloma after total therapy 2: roles of thalidomide and consolidation chemotherapy in the context of total therapy 1Maurizio Zangari, Frits van Rhee, Elias Anaissie, et al.
Plos One|May 12, 2026
Collection of autologous CD34+ hematopoietic progenitor cells (HPC) in multiple myeloma: CD34 + cell collection yield in relation to molecular subtype, karyotype, and FISH resultsAnwar Rjoop, Ivette Perez, Daoud O Al Aruri, et al.
Pageof 24